On July 21st, the 2016 “Dialogue Zhang Jiang†full media interview was held in the fourth session. The current guest speaker was Lou Jingwei, Chairman of Shanghai Baoteng Biomedical Technology Co., Ltd. Xinhua Online Hai July 21st (Reporter He Xinrong) Both patients have lung cancer, seemingly the same symptoms, but using completely different drugs and treatments - the most accurate medicine in recent years, the driving force behind Medical big data . Lou Jingwei, chairman of Shanghai Bao Teng Biomedical Technology Co., Ltd., said on the 21st that by building the world's largest in-house laboratory network to collect the largest data set for a single disease, Bao Teng will provide a winning weapon for the Chinese version of the precision medicine program. For ordinary people, the concept of precision medicine may be somewhat unfamiliar. In the full media interview of “Dialogue Zhang Jiangâ€, Lou Jingwei gave an example: for a thousand cases of lung cancer with A and B drugs, if the statistics A efficiency is 60%, B efficiency is 50%, doctor Drug A may be used in all patients because it is more efficient, which is the popular evidence-based medicine concept. However, after 40% of A drugs are ineffective, this part of people should not accept this treatment, which is the limitation of evidence-based medicine. "With the development of various omics technologies such as genomics, metabolomics, and proteomics, the current science has the ability to find the most suitable treatment for most patients. In this context, precision medicine has emerged. Concept." Lou Jingwei said. At present, both China and the United States have proposed their own precise medical programs. In Lou Jingwei's view, China's huge sample size of patients provides favorable conditions for the development of precision medicine. In the past 8 years, Bao Teng has been collecting enough patient gene and clinical performance data to process it to find out the correlation and provide the basis for the treatment and health management of the next patient. In short, these three things of Bao Tenggan will provide a powerful impetus for the Chinese version of the precision medicine program: A network. With the support of investors such as Sinopharm, Bao Teng has signed a contract with the top three hospitals in China to build 87 molecular medical diagnostic centers, and more than 100 are in talks. Upon completion of these molecular medical diagnostic centers, Bao Teng will have the largest network of in-house laboratories in the world, providing a reliable source of data collection. Two major platforms. There is no doubt that medical big data is a gold mine, and to mine these gold mines, you must go to the "miners" who are cutting-edge technology. As early as 2013, Bao Teng and Fudan University jointly established the Fudan Zhangjiang Clinical Genomics Research Center, led by Prof. Shi Leming, the director of the Medical Genome Center of Fudan University and the “Thousand Talents Program†of the Central Organization Department. In 2014, Bao Teng became one of the undertakers of “Zhejiang National Innovation Demonstration Zone Medical Big Data Service Platform†and advanced to the national team in the field of precision medicine. Tuya Video Doorbell,Smart Doorbell Night Vision,Night Vision Doorbell,Camera Wireless Doorbell Shenzhen Zuomi Technology Co., Ltd. , https://www.zuomicamera.com